NLRC5 negatively regulates inflammatory responses in LPS-induced acute lung injury through NF-κB and p38 MAPK signal pathways

被引:25
作者
Wang, Yuanyuan [1 ,2 ]
Huang, Cheng [1 ]
Bian, Erbao [2 ]
Lei, Ting [2 ]
Lv, Xiongwen [1 ]
Li, Jun [1 ]
机构
[1] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Dept Pharmacol, Hosp 2, 678 Furong Rd, Hefei 230601, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
NLRC5; Acute lung injury; Alveolar macrophage; Inflammatory cytokines; RESPIRATORY-DISTRESS-SYNDROME; RAW264.7; MACROPHAGES; CELLS; ACTIVATION; RECRUITMENT; SECRETION; APOPTOSIS;
D O I
10.1016/j.taap.2020.115150
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute lung injury is an acute inflammatory disease with high morbidity rate and high mortality rate. However, there is still no effective clinical treatment to date. Our previous studies found that NLRC5 was significantly increased in acute liver injury model induced by LPS to reduce the secretion of IL-6 and TNF-alpha. Nevertheless, there is no report on the role of NLRC5 in regulating the development of acute lung injury. In this study we successfully established a model of acute lung injury induced by tracheal instillation of LPS in mice, and found NLRC5 expression was apparently elevated in mouse lung tissue and primary alveolar macrophages. NLRC5 overexpression negatively regulated secretion of inflammatory cytokines in murine alveolar macrophage cells through NF-kappa B and p38 MAPK pathway inhibition. There is a positively feedback between NLRC5 and NF-kappa B or p38 MAPK pathway. This study may provide some new ideas for clinical prevention of lung injury.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-κB, mitochondrial ROS, and MAPK pathways
    Wu, Xiaxia
    Gao, Hongwei
    Hou, Ying
    Yu, Jie
    Sun, Wen
    Wang, Ying
    Chen, Xiaoyan
    Feng, Yulin
    Xu, Qiong-ming
    Chen, Xiuping
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 355 : 1 - 8
  • [32] Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model
    Wang, Xian
    Zhang, Lei
    Duan, Wei
    Liu, Bin
    Gong, Ping
    Ding, Yusong
    Wu, Xiongwen
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 447 - 452
  • [33] Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-κB pathway
    Shen, Weifeng
    Gan, Jianxin
    Xu, Shaowen
    Jiang, Guanyu
    Wu, Honghai
    PHARMACOLOGICAL RESEARCH, 2009, 60 (04) : 296 - 302
  • [34] Madecassoside suppresses LPS-induced TNF-α. production in cardiomyocytes through inhibition of ERK, p38, and NF-κB activity
    Cao, Wei
    Li, Xiao-Qiang
    Zhang, Xiao-Nan
    Hou, Ying
    Zeng, Ai-Guo
    Xie, Yan-hua
    Wang, Si-Wang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (07) : 723 - 729
  • [35] GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-κB Pathways in LPS-Stimulated Microglial Cells
    He, Gai-ying
    Yuan, Chong-gang
    Hao, Li
    Xu, Ying
    Zhang, Zhi-xiong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [36] Peimine ameliorates LPS-induced acute lung injury by regulating Nrf2 and NF-κB pathways
    Huang, Hui
    Wang, Guanhua
    Zeng, Dali
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (10): : 5385 - 5397
  • [37] Linarin prevents LPS-induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF-κB pathways
    Han, Xiang
    Wu, Yi-Chen
    Meng, Min
    Sun, Qing-Song
    Gao, Su-Min
    Sun, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (03) : 1460 - 1472
  • [38] Suppression of MAPK and NF-κB Pathways by Limonene Contributes to Attenuation of Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury
    Chi, Gefu
    Wei, Miaomiao
    Xie, Xianxing
    Soromou, L. W.
    Liu, Fang
    Zhao, Shuhua
    INFLAMMATION, 2013, 36 (02) : 501 - 511
  • [39] Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways
    Tian, Lin
    Li, Weimin
    Wang, Tan
    MICROBIAL PATHOGENESIS, 2017, 108 : 104 - 108
  • [40] Ursodeoxycholic acid alleviates fat embolism syndrome-induced acute lung injury by inhibiting the p38 MAPK/NF-κB signalling pathway through FXR
    He, Xudong
    Shi, Jinye
    Bu, Lina
    Zhou, Shuting
    Wu, Kaixuan
    Liang, Gui
    Xu, Xiaotao
    Wang, Aizhong
    BIOCHEMICAL PHARMACOLOGY, 2024, 230